MoneyWorks4Me

Alembic Pharma receives EIR from USFDA for Panelav facility

15 Jun 2018 Evaluate

Alembic Pharmaceuticals has received Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for the inspection carried out by them at Formulation Facility at Panelav during the period from 12th March, 2018 to 20th March, 2018.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..